Arbutus Biopharma Corporation (ABUS)

NASDAQ: ABUS · Real-Time Price · USD

4.520

+0.110 (2.49%)

At close: Jul 21, 2026, 4:00 PM EDT

4.610

+0.090 (1.99%)

After-hours: Jul 21, 2026, 4:25 PM EDT

Arbutus Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	23.71	18.01	36.33	26.29	30.78	109.28
Short-Term Investments	71.52	73.46	86.29	99.72	116.14	46.04
Cash & Short-Term Investments	95.23	91.47	122.62	126	146.91	155.32
Cash Growth	-15.51%	-25.41%	-2.68%	-14.23%	-5.41%	26.00%
Accounts Receivable	1.31	1.45	2.41	1.78	1.35	0.9
Other Receivables	178.74	-	-	-	-	-
Total Trade Receivables	180.05	1.45	2.41	1.78	1.35	0.9
Other Current Assets	1.73	1.54	2.28	4.25	2.87	4.45
Total Current Assets	277.01	94.46	127.32	132.03	151.14	160.66
Net Property, Plant & Equipment	-	-	1.05	6.09	6.81	8.08
Long-Term Investments	-	-	-	6.28	37.36	35.69
Other Long-Term Assets	0.13	0.13	0.03	-	0.1	0.06
Total Assets	277.16	94.62	131.71	144.4	195.42	204.49
Accounts Payable	4.47	5.46	7.56	10.27	16.03	10.84
Current Portion of Leases	0.63	0.55	0.48	0.43	0.37	0.38
Unearned Revenue	-	-	7.57	11.79	16.46	-
Total Current Liabilities	5.11	6.01	15.62	22.49	32.86	11.22
Long-Term Debt	3.28	3.44	4.83	6.95	10.37	16.3
Long-Term Leases	-	0.2	0.81	1.34	1.82	2.23
Other Long-Term Liabilities	8.6	8.4	13.09	7.6	13.53	5.3
Total Long-Term Liabilities	11.88	12.04	18.72	15.9	25.71	23.83
Total Liabilities	16.99	18.04	34.34	38.38	58.57	35.05
Common Stock	1,444	1,421	1,410	1,350	1,319	1,287
Additional Paid-in Capital	74.26	83.32	82.05	81.27	72.41	65.49
Accumulated Other Comprehensive Income	-48.2	-48.1	-48.14	-48.42	-50.49	-48.34
Retained Earnings	-1,210	-1,380	-1,347	-1,277	-1,204	-1,134
Shareholders' Equity	260.18	76.58	97.37	106.02	136.85	169.44
Total Liabilities & Equity	277.16	94.62	131.71	144.4	195.42	204.49
Total Debt	3.91	4.19	6.12	8.72	12.55	18.91
Net Cash (Debt)	91.32	87.28	116.51	117.28	134.36	136.41
Net Cash Growth	4.62%	-25.08%	-0.66%	-12.71%	-1.50%	35.42%
Net Cash Per Share	0.47	0.46	0.63	0.71	0.89	1.28
Book Value	260.18	76.58	97.37	106.02	136.85	169.44
Book Value Per Share	1.35	0.40	0.52	0.64	0.91	1.59
Tangible Book Value	260.18	76.58	97.37	106.02	136.85	169.44
Tangible Book Value Per Share	1.35	0.40	0.52	0.64	0.91	1.59

SEC Filings: 10-K · 10-Q